Skip to main content
Clinical Trials/JPRN-UMIN000018817
JPRN-UMIN000018817
Recruiting
Phase 2

Japan colorectal tumor prevention study: randomized controlled trial of curcumin - Japan colorectal tumor prevention study: randomized controlled trial of curcumin (J-CAP-C)

Management Committee0 sites600 target enrollmentSeptember 1, 2015

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
colorectal tumor
Sponsor
Management Committee
Enrollment
600
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 1, 2015
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Management Committee

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • \# Patients with a medical history of submucosal or deeper colorectal cancer. \# Patients currently taking antithrombotics such as Bayaspirin, Bufferin, Panaldine, Warfarin, Persantin and NOAC. \# Patients who have undergone colorectal resection (those who have undergone appendectomy are allowed to participate in the study). \# Patients with familial colorectal adenoma. \# Patients with any existing cancer at the time of participation in the study. \# Patients with known allergy to curcumin. \# Patients currently taking anticancer drugs. \# Women who are or may be pregnant during the study period. \# Patients currently taking NSAIDs at least 3 times weekly, for example, as a analgesic. \# Patients with ulcerative colitis or Crohn's disease \# Patients with bleeding tendency or platelet count less than 70,000\. \# Patient taking turmeric as a supplement. \# Patient deemed inappropriate by a doctor

Outcomes

Primary Outcomes

Not specified

Similar Trials